Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CXCL13 as a Novel Immune Checkpoint for Regulatory B Cells and Its Role in Tumor Metastasis
Jun Ren, Tianxia Lan, Ting Liu, et al.
The Journal of Immunology (2022) Vol. 208, Iss. 10, pp. 2425-2435
Open Access | Times Cited: 21

Showing 21 citing articles:

Cellular senescence and metabolic reprogramming: Unraveling the intricate crosstalk in the immunosuppressive tumor microenvironment
Fusheng Zhang, Junchen Guo, Shengmiao Yu, et al.
Cancer Communications (2024) Vol. 44, Iss. 9, pp. 929-966
Open Access | Times Cited: 14
Immune Cell Migration to Cancer
Allison Ryan, Minsoo Kim, Kihong Lim
Cells (2024) Vol. 13, Iss. 10, pp. 844-844
Open Access | Times Cited: 12
B cells and the coordination of immune checkpoint inhibitor response in patients with solid tumors
Ronan Flippot, Marcus de Melo Teixeira, Macarena Rey-Cárdenas, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 4, pp. e008636-e008636
Open Access | Times Cited: 8
A potential area of use for immune checkpoint inhibitors: Targeting bone marrow microenvironment in acute myeloid leukemia
Başak Aru, Cemil Pehlivanoğlu, Zeynep Dal, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 13
Innate immune checkpoint inhibitor resistance is associated with melanoma sub-types exhibiting invasive and de-differentiated gene expression signatures
Sultana Mehbuba Hossain, Grégory Gimenez, Peter A. Stockwell, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 20
B cells in tumor metastasis: friend or foe?
Yuqiu Xu, Yihao Mao, Yang Lv, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 8, pp. 2382-2393
Open Access | Times Cited: 12
Multifaceted function of B cells in tumorigenesis
Na Kang, Qinghui Duan, Xin Min, et al.
Frontiers of Medicine (2025)
Closed Access
Anti‐Tumour Immunity Relies on Targeting Tissue Homeostasis Through Monocyte‐Driven Responses Rather Than Direct Tumour Cytotoxicity
Nicholas Koelsch, Faridoddin Mirshahi, Hussein F. Aqbi, et al.
Liver International (2025) Vol. 45, Iss. 5
Open Access
Microenvironmental Snail1-induced immunosuppression promotes melanoma growth
Marta Arumí-Planas, Francisco Javier Rodríguez‐Baena, Francisco Cabello-Torres, et al.
Oncogene (2023) Vol. 42, Iss. 36, pp. 2659-2672
Open Access | Times Cited: 10
Considerations and Approaches for Cancer Immunotherapy in the Aging Host
Carlos O. Ontiveros, Clare Murray, Grace E. Crossland, et al.
Cancer Immunology Research (2023) Vol. 11, Iss. 11, pp. 1449-1461
Open Access | Times Cited: 7
Proteogenomic characterization identifies clinical subgroups in EGFR and ALK wild-type never-smoker lung adenocarcinoma
Hyondeog Kim, Wonyeop Lee, Young-Wook Kim, et al.
Experimental & Molecular Medicine (2024)
Open Access | Times Cited: 1
COADREADx: A comprehensive algorithmic dissection of colorectal cancer unravels salient biomarkers and actionable insights into its discrete progression
Ashok Palaniappan, Sangeetha Muthamilselvan, Arjun Sarathi
PeerJ (2024) Vol. 12, pp. e18347-e18347
Open Access | Times Cited: 1
Immune Checkpoints in B Cells: Unlocking New Potentials in Cancer Treatment
Xiaoye Shi, Xiangshu Cheng, Aimin Jiang, et al.
Advanced Science (2024)
Open Access | Times Cited: 1
A Retrospective Exploratory Analysis for Serum Extracellular Vesicles Reveals APRIL (TNFSF13), CXCL13, and VEGF-A as Prognostic Biomarkers for Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer
Hae Hyun Jung, Ji‐Yeon Kim, Eun Yoon Cho, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15576-15576
Open Access | Times Cited: 2
Transcriptome analysis reveals the clinical significance of CXCL13 in Pan-Gyn tumors
Yue Ding, Quan Zhou, Bo Ding, et al.
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 3
Open Access
Effective anti-tumor immune response against HCC is orchestrated by immune cell partnership network that functions through hepatic homeostatic pathways, not direct cytotoxicity
Nicholas Koelsch, Faridoddin Mirshahi, Hussein F. Aqbi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Serum CXCL13 as a Novel Biomarker in Oral Squamous Cell Carcinoma
Shin Tojo, Koh‐ichi Nakashiro, Nobuyuki Kuribayashi, et al.
Cancer Medicine (2024) Vol. 13, Iss. 18
Open Access
Gene expression levels associated with impaired immune response and increased proliferation could serve as biomarkers for women following cervical cancer screening programmes
Irene Tveiterås Øvestad, Ingvild Dalen, Kristiane Søreng, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
The dichotomy of regulatory B cells in cancer versus allergic disease
Melissa Dang, Justin Yu, Jessica Galant‐Swafford, et al.
Molecular Carcinogenesis (2023) Vol. 63, Iss. 1, pp. 11-21
Open Access | Times Cited: 1
COADREADx: A comprehensive algorithmic dissection unravels salient biomarkers and actionable insights into the discrete progression of colorectal cancer
Ashok Palaniappan, Sangeetha Muthamilselvan, Arjun Sarathi
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Microenvironmental Snail1 is a driver of immunosuppression in melanoma
Marta Arumí-Planas, Francisco Javier Rodríguez‐Baena, Francisco Cabello-Torres, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Page 1

Scroll to top